CD274 and neoplasm: ID8p53–/– Brca2–/–-Egfl6 tumor-bearing mice treated with a-Egfl6 + a-PD-L1 showed a significantly prolonged survival (median survival = 57) compared with IgG isotype control (median survival = 48) (P value 0.0011).